The influence of age and sex on the clearance of cytochrome P450 3A substrates.
about
Pharmacogenetics as a tool to tailor antiretroviral therapy: A reviewFemale-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesVitamin E in human health and diseaseSex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analysesAutoimmune-like drug-induced liver injury: a review and update for the clinician.Sedation and analgesia usage in severe pandemic H1N1 (2009) infection: a comparison to respiratory failure secondary to other infectious pneumonias.Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort.Effect of hepatic function on the EC50 of midazolam and the BIS50 at the time of loss of consciousness.Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence.Outcome of acute liver failure in the elderlyPopulation analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 yearsRisk factors for idiosyncratic drug-induced liver injury.EPMA position paper in cancer: current overview and future perspectives.Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics.Gender-based personalized pharmacotherapy: a systematic review.The clinical implications of antiretroviral pharmacogenomics.Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.Predicted metabolic drug clearance with increasing adult age.Clinical pharmacology in the geriatric patient.Clinical pharmacokinetics of antiretroviral drugs in older persons.Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomesSex-specific differences in CYP450 isoforms in humans.Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs.Sex differences in the expression of hepatic drug metabolizing enzymes.Pharmacologic consideration for the use of antiretroviral agents in the elderly.Clinical characteristics of drug-induced liver injury and related risk factors.Pharmacogenomics of CYP3A: considerations for HIV treatment.Importance of hematocrit for a tacrolimus target concentration strategy.Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans.Are TKIs favourable for the elderly with non-small-cell lung cancer?State of the art in therapeutic drug monitoring.Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseDrug-induced autoimmune-like hepatitis.
P2860
Q26797938-59C1442E-A689-4639-BD82-B8D0819F8A68Q28182631-CB76D878-312C-4219-8727-18576BE4DDA1Q28291248-923C9B6E-441B-45EA-A911-E065ECF34005Q28593306-0FBE86C5-2C37-4578-96D8-FD542653E48AQ30276377-AA6E8090-ECAB-442F-97F5-979D7272662FQ30410665-918CA6DD-38CC-4C69-88E3-D508AB93EAA6Q33710324-4EB78469-9B21-4C9B-AFA7-E8BBDA928706Q34020658-536CB520-AD04-4657-8558-72DBDB3115F2Q34029472-63518F14-15DE-47C8-8AB1-DCC1F9783960Q34100187-6E8D9D28-B126-4FB1-98E7-A093FBF010F8Q34792547-2409AD59-7F38-4D8E-9338-C13E42BBBFB4Q34815981-529C7448-1F7A-4547-BB28-4C347A8FAFB9Q35068921-7450017C-190F-49C6-922B-237B77B4512BQ35127775-8092FF6E-706A-4DF7-9489-348E184FC69CQ35168108-6695FC7C-D485-47CE-9940-A920B39C4141Q35532215-2FDF4E8F-DE96-4AD7-B0E5-0304C7B45277Q35865260-EE26A5E0-B2F0-4970-907E-E8052354E320Q35972237-40554363-E7C9-4DFD-AAE0-05690C7B6C51Q36024890-68E84E13-D6A4-4147-A8BA-34B4FDB1B7D6Q36335289-42CF9A71-F26F-4513-81A4-5CE75C3E1EADQ36497078-DD11E6CB-586C-44A4-B647-F2084F1C1791Q36546272-9BDDC3F5-8E3A-4F48-946F-A77B85958B06Q36599937-8ED5DD86-9181-4EA6-AC3B-FC7FA7ED81FCQ36729942-79556986-BA70-4DE9-A513-BD63BD9AD74AQ36830192-37523DD6-BC47-4F1F-BEC5-4EE5A4D89A67Q36905884-1AC8C099-D615-4DFD-B181-08215800BAD5Q36989348-573CC3CA-D134-4BFE-BFFD-4E0E6DE9A6EEQ37029122-4FD77229-2E7A-42B2-9097-584CF68D59D7Q37181876-CF5DF63A-F625-49A3-BE03-974CAE60EB8BQ37256195-63D60D5A-5EF0-42D4-8A9C-E05154C9528FQ37268108-0B1BFEDD-CD8F-47AD-9952-7B70BAB57BC4Q37277510-5D099DA6-231B-456A-8F7C-F93C63B73999Q37289416-CAC36FCA-923D-429D-9B60-F3537F730A56Q37419542-F93E75DD-D5A0-4607-A013-E27E9962E1CBQ37469289-384BE00D-3401-47A5-AEA1-D291D84BFDA1Q37498669-3BFF7E97-E728-48D5-9C67-46072F7DE666Q37564967-1DF5E4A4-D729-49C9-BB26-5079B77FD90BQ37699413-2E28AF82-4B72-4A8E-ADA2-4F3CEA27516FQ37828179-9B81F6BF-35C9-40A4-9370-DD7689450E55Q37843783-8E31D625-A19A-404B-8C80-F052DC758EF7
P2860
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@ast
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@en
type
label
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@ast
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@en
prefLabel
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@ast
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@en
P2093
P1476
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
@en
P2093
David J Greenblatt
Lisa L von Moltke
Monette M Cotreau
P356
10.2165/00003088-200544010-00002
P577
2005-01-01T00:00:00Z
P6179
1048453618